Metoprolol Succinate Extended Release Tablets

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Metoprolol succinate 23.75 mg equivalent to metoprolol tartrate 25mg
Available from:
AFT Pharmaceuticals Ltd
INN (International Name):
Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)
Dosage:
23.75 mg
Pharmaceutical form:
Modified release tablet
Composition:
Active: Metoprolol succinate 23.75 mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres
Prescription type:
Prescription
Manufactured by:
Watson Pharma Private Limited
Therapeutic indications:
Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
Product summary:
Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-9995
Authorization date:
2016-06-24

Similar products

Search alerts related to this product

Share this information